Cargando…
Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report
• Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such clinical scenario. • Mycophenolate mofetil can be contributory cause of PRES. • Prompt recognition and timely intervention is a key to full recover...
Autores principales: | Khanal, Sushil, Chaudhary, Rohit Kumar, Kc, Kripa, Lamichhane, Supriya, Kathayat, Sarita, Acharya, Subash Prasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895702/ https://www.ncbi.nlm.nih.gov/pubmed/33643649 http://dx.doi.org/10.1016/j.amsu.2021.01.095 |
Ejemplares similares
-
Mycophenolate Mofetil for Severe IgA Vasculitis Nephropathy in Children: An Observational Study
por: Samsonov, Dmitry, et al.
Publicado: (2022) -
Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children
por: Kang, Zhijuan, et al.
Publicado: (2015) -
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
por: Chen, Youyuan, et al.
Publicado: (2014) -
Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis
por: Du, Bing, et al.
Publicado: (2017) -
A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]
por: Hogg, Ronald J, et al.
Publicado: (2004)